Single arm Phase I/II study of the safety, tolerability and efficacy of the Tocilizumab followed by cisplatin/docetaxel in patients with triple negative locally advanced breast cancer
2020-07-04
عنوان الدراسة
Single arm Phase I/II study of the safety, tolerability and efficacy of the Tocilizumab followed by cisplatin/docetaxel in patients with triple negative locally advanced breast cancer
داعم الدراسة
King Faisal Specialist Hospital and Research Centre
دواء الدراسة
• TOCILIZUMAB (ACTEMRA)• DOCETAXEL (TAXOTERE)• CISPLATIN
رقم بروتوكول الدراسة
2181156
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
2a
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。